{"filing":{"accession_number":"0001213900-26-077049","cik":"0001023994","ticker":"OLOX","company_name":"OLENOX INDUSTRIES INC.","form":"8-K","filing_date":"2026-07-10","report_date":null,"primary_document":"ea0297668-8k_olenox.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1023994/000121390026077049/ea0297668-8k_olenox.htm"},"events":[{"id":17282,"run_id":15464,"accession_number":"0001213900-26-077049","anchor_item_number":"2.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"summary":"Olenox Industries acquired 100% of the issued and outstanding shares of Psylinks Neurotech Corp. on July 3, 2026, for US$500,000 in restricted common stock, making Psylinks a wholly owned subsidiary and expanding the Company's strategic presence in neurotechnology and applied intelligence platforms.","company_name":"OLENOX INDUSTRIES INC.","ticker":"OLOX","filing_date":"2026-07-10","form":"8-K","submitted_at":null,"items":[{"id":15658,"accession_number":"0001213900-26-077049","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The filing discloses entry into a Stock Exchange Agreement on July 3, 2026, pursuant to which Olenox Industries acquired 100% of the issued and outstanding shares of Psylinks Neurotech Corp. for US$500,000 in restricted common stock. This is a material acquisition of a target company, clearly falling under Item 1.01 (Entry into a Material Definitive Agreement) and constituting M\u0026A activity that would affect a reasonable investor's assessment of the registrant's strategic direction and capital deployment.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T17:34:42.055706+00:00","company_name":"","ticker":null,"filing_date":""},{"id":15659,"accession_number":"0001213900-26-077049","item_number":"2.01","item_title":"Completion of Acquisition or Disposition","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"The filing discloses completion of an acquisition of 100% of Psylinks' issued and outstanding shares on July 3, 2026, making Psylinks a wholly owned subsidiary. This is a material acquisition event under Item 2.01, representing a significant capital deployment and strategic expansion into neurotechnology and applied intelligence platforms.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T17:34:42.055706+00:00","company_name":"","ticker":null,"filing_date":""},{"id":15660,"accession_number":"0001213900-26-077049","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The Item 3.02 disclosure incorporates Item 1.01 (a material acquisition) by reference and describes the issuance of $500,000 in Common Stock as consideration for the acquisition of Psylinks shares. While Item 3.02 technically addresses the unregistered equity issuance, the core material event is the acquisition itself, which is the principal transaction driving the equity issuance. The reference to Item 1.01 and the acquisition context make ma_activity the most salient classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T17:34:42.055706+00:00","company_name":"","ticker":null,"filing_date":""},{"id":15661,"accession_number":"0001213900-26-077049","item_number":"8.01","item_title":"Other Events.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"reasoning":"The filing discloses an acquisition of Psylinks with issuance of Common Stock shares and integration of Psylinks' operations into the Company. The forward-looking statements explicitly reference \"the expected benefits of the Acquisition\" and \"the ability to integrate Psylinks' operations,\" indicating a material M\u0026A transaction that would affect investor assessment of the registrant's future business and financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T17:34:42.055706+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":15658,"accession_number":"0001213900-26-077049","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The filing discloses entry into a Stock Exchange Agreement on July 3, 2026, pursuant to which Olenox Industries acquired 100% of the issued and outstanding shares of Psylinks Neurotech Corp. for US$500,000 in restricted common stock. This is a material acquisition of a target company, clearly falling under Item 1.01 (Entry into a Material Definitive Agreement) and constituting M\u0026A activity that would affect a reasonable investor's assessment of the registrant's strategic direction and capital deployment.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T17:34:42.055706+00:00","company_name":"OLENOX INDUSTRIES INC.","ticker":"OLOX","filing_date":"2026-07-10"},{"id":15659,"accession_number":"0001213900-26-077049","item_number":"2.01","item_title":"Completion of Acquisition or Disposition","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"The filing discloses completion of an acquisition of 100% of Psylinks' issued and outstanding shares on July 3, 2026, making Psylinks a wholly owned subsidiary. This is a material acquisition event under Item 2.01, representing a significant capital deployment and strategic expansion into neurotechnology and applied intelligence platforms.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T17:34:42.055706+00:00","company_name":"OLENOX INDUSTRIES INC.","ticker":"OLOX","filing_date":"2026-07-10"},{"id":15660,"accession_number":"0001213900-26-077049","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The Item 3.02 disclosure incorporates Item 1.01 (a material acquisition) by reference and describes the issuance of $500,000 in Common Stock as consideration for the acquisition of Psylinks shares. While Item 3.02 technically addresses the unregistered equity issuance, the core material event is the acquisition itself, which is the principal transaction driving the equity issuance. The reference to Item 1.01 and the acquisition context make ma_activity the most salient classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T17:34:42.055706+00:00","company_name":"OLENOX INDUSTRIES INC.","ticker":"OLOX","filing_date":"2026-07-10"},{"id":15661,"accession_number":"0001213900-26-077049","item_number":"8.01","item_title":"Other Events.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"reasoning":"The filing discloses an acquisition of Psylinks with issuance of Common Stock shares and integration of Psylinks' operations into the Company. The forward-looking statements explicitly reference \"the expected benefits of the Acquisition\" and \"the ability to integrate Psylinks' operations,\" indicating a material M\u0026A transaction that would affect investor assessment of the registrant's future business and financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T17:34:42.055706+00:00","company_name":"OLENOX INDUSTRIES INC.","ticker":"OLOX","filing_date":"2026-07-10"}]}